S-23

Here’s something I learned the hard way after years of researching performance compounds: the ones that promise the most dramatic results usually come with the most dramatic trade-offs. S-23 is a perfect example.

This selective androgen receptor modulator (SARM) has gained attention in research communities for its potent effects on muscle tissue and emerging evidence of cognitive effects through androgen receptor pathways in the brain. But here’s the reality — it’s also one of the most suppressive SARMs studied, with a research profile that demands serious consideration before use.

The Short Version: S-23 is an investigational SARM that activates androgen receptors in muscle and potentially in brain regions involved in motivation and reward. Research protocols have used 10-30 mg daily. The compound shows promise for physical performance enhancement but comes with significant hormonal suppression and safety considerations. This is not a beginner compound.

Research Chemical Notice: S-23 is an investigational compound that has not been approved by the FDA for human use. The information below is compiled from published research for educational purposes only. This is not medical advice and should not be interpreted as a recommendation for human consumption. Always consult a qualified healthcare provider.

What Is S-23?

S-23 is a non-steroidal selective androgen receptor modulator (SARM) originally developed by GTx, Inc. for potential treatment of muscle wasting conditions and male hormonal contraception. Unlike anabolic steroids that activate androgen receptors throughout the body indiscriminately, SARMs like S-23 were designed to selectively target muscle and bone tissue while theoretically minimizing effects on other organs.

The “selective” part of selective androgen receptor modulator is somewhat misleading with S-23. Research shows it’s highly tissue-selective for muscle, but it’s also significantly more suppressive to natural testosterone production than other SARMs like Ostarine or LGD-4033. In animal studies, S-23 was potent enough to be investigated as a potential male contraceptive due to its suppression of luteinizing hormone (LH) and follicle-stimulating hormone (FSH).

Why does this matter for cognitive function? Androgen receptors aren’t just in muscle tissue — they’re densely concentrated in brain regions involved in motivation, reward processing, and energy regulation. This is where the nootropic interest comes in, though I’ll be upfront: the cognitive research on S-23 specifically is thin. Most of what we know comes from broader androgen receptor research and user reports in research communities.

Reality Check: S-23 is not a “brain supplement” in the traditional sense. It’s a research chemical with powerful hormonal effects. If you’re looking for cognitive enhancement without hormonal suppression, you’d be better served by compounds like Bacopa Monnieri, Lion’s Mane, or Alpha-GPC.

How Does S-23 Work? (The Mechanisms That Matter)

Understanding how S-23 works requires understanding what androgen receptors actually do in the brain and body.

The basic mechanism: S-23 binds to androgen receptors with high affinity — research suggests binding affinity comparable to or exceeding dihydrotestosterone (DHT), one of the most potent natural androgens. When it binds to these receptors in muscle tissue, it triggers anabolic signaling pathways that increase protein synthesis and reduce protein breakdown. In the brain, androgen receptor activation influences dopaminergic pathways and neural circuits involved in motivation and reward.

Here’s what makes S-23 different from something like testosterone. Traditional anabolic steroids activate androgen receptors everywhere they’re found — muscle, prostate, brain, liver, skin. SARMs were engineered to have tissue-selective activity, binding strongly to receptors in muscle and bone while theoretically having weaker effects elsewhere. In practice, S-23’s selectivity profile is more complex than initially hoped.

The dopaminergic connection: Androgen receptors are present in brain regions like the ventral tegmental area (VTA) and nucleus accumbens — the core components of the brain’s reward circuitry. Research on androgen receptor activation in these areas has found increased dopamine signaling and enhanced motivation for goal-directed behaviors. This is why androgens have been linked to increased drive, competitiveness, and what some research describes as “approach motivation.”

The energy pathway: S-23 may indirectly influence energy metabolism through its effects on muscle function and body composition. Improved muscle efficiency and reduced fatigue could optimize the body’s stress response systems and energy mobilization, though this effect is secondary to the direct androgen receptor activation.

Pro Tip: The cognitive effects of S-23 — if they occur — are likely indirect consequences of androgen receptor activation rather than direct nootropic mechanisms. Think of it as improved physical capacity potentially supporting mental drive, not as a targeted cognitive enhancer.

Reported Effects of S-23 (What the Research Shows)

Let’s be honest about the evidence here. Most S-23 research has focused on muscle and bone outcomes, not cognitive performance. What we know about potential brain effects comes primarily from:

1. Animal studies on androgen receptor function in the brain
2. User reports in research communities
3. Extrapolation from broader androgen research

Here’s what the research suggests, with honest assessment of evidence quality:

Physical effects (well-documented): Animal research on S-23 has consistently demonstrated dose-dependent increases in lean muscle mass, bone mineral density, and fat mass reduction. These effects occur at relatively low doses compared to traditional androgens.

Potential cognitive effects (speculative): Based on what we know about androgen receptor activation in the brain, S-23 could theoretically influence:

• Motivation and goal-pursuit — Androgen receptor activation in the nucleus accumbens and VTA has been linked to increased motivation for reward-seeking behaviors and enhanced persistence in goal-directed tasks.

• Competitive drive — Research on androgens broadly suggests enhanced competitiveness and reduced fear of social dominance challenges, mediated through androgen receptor pathways in the amygdala and prefrontal cortex.

• Energy perception — Improved physical conditioning and reduced fatigue may create a subjective sense of increased mental energy and capacity, though this is indirect.

The critical caveat: none of these cognitive effects have been studied specifically with S-23 in controlled human trials. We’re inferring from mechanism and broader research.

Reality Check: If you’re specifically looking for cognitive enhancement backed by direct human research, you’d be better served by compounds with established nootropic profiles like Rhodiola Rosea for motivation, L-Tyrosine for dopamine support, or Citicoline for focus and memory.

Research Administration Protocols (Doses Used in Studies)

Research on S-23 has investigated a range of doses, primarily in animal models. Translating these to human equivalent doses requires caution, but research communities have reported typical ranges based on extrapolation and anecdotal use.

Timing and absorption: Studies have suggested taking S-23 with food to enhance absorption. The compound’s half-life is estimated at 12-24 hours based on pharmacokinetic data, which supports once-daily dosing. Some research protocols have investigated split dosing (morning and evening) to maintain more stable blood levels.

Cycle length: Most research investigating S-23’s effects has used protocols ranging from 8-12 weeks. Longer durations increase the risk of hormonal suppression and potential adverse effects on lipid profiles and liver function.

Post-cycle considerations: Due to S-23’s suppressive effects on natural testosterone production, research protocols have often included post-cycle therapy (PCT) phases using compounds like Clomiphene or Tamoxifen to help restore endogenous hormone production. This is not a compound you simply stop using without consideration for hormonal recovery.

Important: S-23 is one of the most suppressive SARMs studied. Research has shown significant reductions in luteinizing hormone (LH) and follicle-stimulating hormone (FSH) even at moderate doses. If you’re considering research use, comprehensive hormone panel testing before, during, and after is non-negotiable.

Bioavailability factors: Oral administration appears effective based on research reports, though like many SARMs, S-23 undergoes first-pass metabolism in the liver. Taking it with dietary fat may enhance absorption, similar to other lipophilic compounds.

Starting protocols in research: Conservative approaches in research communities typically start at the lower end of the dosing range (10 mg) for 2-4 weeks to assess individual response and side effect profile before considering any increase.

Adverse Events & Safety Profile (What Could Go Wrong)

This is where S-23 gets serious. It’s not a benign compound, and anyone considering research use needs to understand the full risk profile.

Hormonal suppression (highly likely): This is the big one. Research suggests S-23 significantly suppresses natural testosterone production, likely more than other popular SARMs. Animal studies showed dose-dependent reductions in LH and FSH, the hormones that signal your testes to produce testosterone. In practical terms, this means:

• Reduced testosterone levels during use
• Potential fertility impacts (it was literally studied as a male contraceptive)
• Possible long-term suppression if recovery protocols aren’t followed
• Symptoms of low testosterone: reduced libido, fatigue, mood changes, loss of muscle mass

Lipid profile changes: Research has indicated potential negative effects on cholesterol, including:

• Reduced HDL (good cholesterol)
• Increased LDL (bad cholesterol)
• Elevated triglycerides in some cases

Liver stress: While SARMs are non-methylated (unlike many oral steroids), research has still reported potential liver enzyme elevations with S-23 use. This appears dose-dependent.

Androgenic side effects: Despite being “selective,” S-23 can still cause androgenic effects:

• Acne and oily skin
• Hair loss in those genetically predisposed
• Increased aggression or irritability
• Prostate growth (though research suggests less than traditional androgens)

Documented side effects by frequency:

Drug and substance interactions:

Who should absolutely avoid research with S-23:

• Anyone under 25 (developing endocrine system)
• Women (high risk of virilization effects)
• People with existing liver conditions
• Those with cardiovascular disease or poor lipid profiles
• Anyone with hormone-sensitive cancers
• People with psychiatric conditions aggravated by hormonal changes

Important: The long-term safety profile of S-23 in humans is unknown. Most research is in animal models or short-term human observations. If you have any pre-existing health conditions, this is not a compound to experiment with casually.

Investigated Combinations in Research

Research communities have explored various combinations with S-23, though formal research on these stacks is extremely limited. Here’s what’s been investigated:

For Muscle Growth + Performance Enhancement:

• S-23 (10-20 mg) + MK-677 (25 mg) + Creatine Monohydrate (5 g)
  • Timing: S-23 once daily with breakfast, MK-677 before bed, creatine any time
  • Rationale: MK-677 provides GH/IGF-1 support while potentially offsetting some metabolic suppression; creatine enhances strength and cognitive function
  • Risk: Increased appetite from MK-677, compounded suppression

For Body Recomposition + Recovery:

• S-23 (15 mg) + GW-501516 (10-20 mg) + BPC-157 (250-500 mcg)
  • Timing: S-23 morning with food, GW-501516 pre-workout, BPC-157 subcutaneous daily
  • Rationale: GW-501516 enhances fat oxidation and endurance; BPC-157 supports tissue repair
  • Risk: GW-501516 has concerning long-term safety data; BPC-157 is investigational

For Post-Cycle Recovery (PCT):

• Clomiphene (25-50 mg) + D-Aspartic Acid (3 g) + Ashwagandha (600 mg KSM-66)
  • Timing: 4-6 weeks post-S-23 cycle
  • Rationale: Clomiphene stimulates LH/FSH recovery; DAA may support testosterone synthesis; ashwagandha reduces cortisol and supports hormonal balance
  • Note: This is a research-based recovery protocol, not a preventive measure

Synergy considerations:

What to AVOID combining:

• Other suppressive SARMs or steroids — Compounding hormonal shutdown is dangerous and offers diminishing returns
• Hepatotoxic compounds — Methylated oral steroids, high-dose N-Acetylcysteine (NAC) paradoxically, or excessive alcohol
• Stimulants in excess — S-23 may increase aggression/irritability; high caffeine or DMAA could exacerbate this
• Aromatase inhibitors without medical guidance — Can crash estrogen during an already hormonally complex situation

Pro Tip: If you’re considering S-23 research, keep the stack simple. Adding multiple investigational compounds simultaneously makes it impossible to isolate what’s causing benefits or side effects. Get comprehensive bloodwork before, at mid-point, and after any research cycle.

Current Research Assessment

Let me be direct: S-23 sits in a complicated space. The research on its muscle-building properties is genuinely interesting — it shows strong tissue selectivity and significant anabolic effects in animal models. But the cognitive angle? That’s mostly speculation based on androgen receptor mechanisms, not direct S-23 research.

If you’re primarily interested in cognitive enhancement, this is not your compound. The hormonal suppression, lipid impacts, and liver stress create a risk-benefit ratio that doesn’t make sense when there are dozens of compounds with better-established nootropic profiles and far fewer risks. Rhodiola Rosea for motivation, L-Tyrosine for dopamine support, Bacopa Monnieri for memory — these work through complementary mechanisms without shutting down your endocrine system.

Who might find S-23 research valuable:

• Experienced researchers with prior SARM cycles who understand hormonal management
• Those specifically investigating body recomposition and willing to accept the trade-offs
• People with comprehensive bloodwork monitoring and post-cycle recovery protocols in place
• Individuals who’ve exhausted natural optimization of training, nutrition, and sleep

Who should absolutely look elsewhere:

• Anyone new to research chemicals or SARMs
• People under 25 with developing hormonal systems
• Those without access to regular bloodwork and medical monitoring
• Anyone looking primarily for cognitive benefits — try Citicoline, Lion’s Mane, or Phosphatidylserine instead

The evidence quality matters here. We have decent animal research on S-23’s physical effects. We have good mechanistic research on androgen receptors in the brain broadly. But we have essentially no controlled human research on S-23’s cognitive effects specifically. That’s a lot of extrapolation for a compound with real hormonal consequences.

Reality Check: The most powerful nootropic isn’t a pill — it’s addressing the fundamentals. If your sleep is broken, your gut is inflamed, your stress is chronic, and your nutrition is poor, S-23 (or any compound) isn’t going to fix your cognitive performance. Get the foundations right first. That’s not sexy, but it’s what actually works long-term.

My honest assessment of the current research: S-23 is a potent investigational compound with legitimate applications in body composition research, but its cognitive effects are largely theoretical and its risks are well-documented. If you’re going to engage with this level of research chemical, do it with eyes wide open, comprehensive monitoring, and a clear understanding that you’re operating in territory with limited human safety data.

If the idea of suppressing your natural testosterone production for months and requiring a recovery protocol to restore hormonal function sounds unappealing — good instinct. Listen to it. There are safer paths to cognitive enhancement.